✦ LIBER ✦

Molecular subtypes of breast cancer in relation to paclitaxel response and outcomes in women with metastatic disease: results from CALGB 9342

✍ Scribed by Lyndsay N Harris, Gloria Broadwater, Nancy U Lin, Alexander Miron…

Book ID: 120700283
Publisher: BioMed Central
Year: 2006
Tongue: English
Weight: 372 KB
Volume: 8
Category: Article
ISSN: 1465-5411
DOI: 10.1186/bcr1622

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Failure of Higher-Dose Paclitaxel to Imp

Failure of Higher-Dose Paclitaxel to Improve Outcome in Patients With Metastatic Breast Cancer: Cancer and Leukemia Group B Trial 9342

✍ Holmes, F.A. 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 56 KB

Interleukin-6, multidrug resistance prot

Interleukin-6, multidrug resistance protein-1 expression and response to paclitaxel in women with metastatic breast cancer: results of cancer and leukemia group B trial 159806

✍ Mercedes Rincon; Gloria Broadwater; Lyndsay Harris; Abigail Crocker; Donald Weav 📂 Article 📅 2006 🏛 Springer US 🌐 English ⚖ 204 KB

Patterns of Recurrence and Outcome Accor

Patterns of Recurrence and Outcome According to Breast Cancer Subtypes in Lymph Node-Negative Disease: Results From International Breast Cancer Study Group Trials VIII and IX

✍ Metzger-Filho, O.; Sun, Z.; Viale, G.; Price, K. N.; Crivellari, D.; Snyder, R. 📂 Article 📅 2013 🏛 American Society of Clinical Oncology 🌐 English ⚖ 181 KB

Breast Cancer Molecular Subtypes in Pati

Breast Cancer Molecular Subtypes in Patients With Locally Advanced Disease: Impact on Prognosis, Patterns of Recurrence, and Response to Therapy

✍ Kathryn E. Huber; Lisa A. Carey; David E. Wazer 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 210 KB

Molecular profiling and predictive value

Molecular profiling and predictive value of circulating tumor cells in patients with metastatic breast cancer: an option for monitoring response to breast cancer related therapies

✍ Mitra Tewes; Bahriye Aktas; Anja Welt; Siemke Mueller; Siegfried Hauch; Rainer K 📂 Article 📅 2008 🏛 Springer US 🌐 English ⚖ 377 KB

Evaluating health-related quality-of-lif

Evaluating health-related quality-of-life therapeutic effectiveness in a clinical trial with extensive nonignorable missing data and heterogeneous response: results from a phase III randomized trial of gemcitabine plus paclitaxel versus paclitaxel monotherapy in patients with metastatic breast cancer

✍ Carol M. Moinpour, Gary W. Donaldson, Astra M. Liepa, Allen S. Melemed, Joyce O’ 📂 Article 📅 2011 🏛 Springer Netherlands 🌐 English ⚖ 392 KB